Renishaw plc

Reported revenue increased 7.1% year over year to a record first half, or 11.5% at constant currency. Operating profit rose 11.4% to GBP 57.5 million and profit before tax rose 11.5% to GBP 64.1 million; operating margin improved by 0.6 percentage points to 15.7%. The effective tax rate was 21.1% reported and 21.8% adjusted, and the interim dividend stayed at 16.8p. By region, the Americas grew more than 15% reported and more than 20% constant currency, APAC grew more than 10% reported and more than 15% constant currency, and EMEA revenue fell around 5%. The company cited around GBP 5 million of higher pricing/surcharging in the Americas to offset tariff duties and around GBP 5 million of revenue from currency hedging, while FX still created roughly GBP 13.2 million of headwind to margin. Cost actions included a GBP 20 million annualized reduction program, a GBP 3 million annualized benefit from closing drug delivery, GBP 9 million of savings in the first half, CapEx of GBP 17 million in H1, expected CapEx of about GBP 40 million for the year, cash balances just over GBP 240 million, ROIC of 13.2%, and cash conversion just below target at 68%. Management guided for strong revenue and profit growth for the year ahead, while noting continued currency headwinds, some benefit from cost reduction, and revenue flow-through in H2.

William Lee emphasized that the quarter validated Renishaw’s strategy of long-term growth through product innovation, especially in emerging businesses and new product launches. He said Q2 showed a real pickup in demand even though end markets remain mixed, with particular strength in semiconductor-related equipment, defense, and selected automation areas. His tone was upbeat but measured: he repeatedly highlighted uncertainty in the short term while saying the company has momentum into H2 and is excited about the medium- to long-term opportunity.

Marc Saunders focused on the mechanics behind the improved results: higher revenue, better operating leverage, and cost savings were partly offset by FX headwinds. He quantified the currency drag at roughly GBP 13.2 million on margin, noted GBP 9 million of savings from cost programs in the half, and explained that headcount fell about 7% to just below 5,000 employees at the end of December. He also pointed to cash of just over GBP 240 million, CapEx of GBP 17 million in H1 with about GBP 40 million expected for the full year, and cash conversion of 68%, slightly below target.

Analysts pressed on China entry-level strategy, additive manufacturing scaling, defense exposure, the order book, ERP implementation, German machine tool weakness, humanoids, and the margin profile of emerging products. Management said China testing is limited for now but that engineering is developing lower-cost designs for entry-level opportunities; additive is being sold to both existing and new customers, with defense helping but development still uneven. On defense, they said it is still a relatively small share, though growing from a historical level around 5%, and on the order book they cautioned that it is helpful for direction but not fully reliable because call-off orders can appear and disappear quickly. They also said the ERP rollout has been challenging, Germany will be next, and humanoids are not a meaningful opportunity because the relevant encoder market may be too commoditized and low-end.